Patents by Inventor Greg Hannigan

Greg Hannigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of inflammatory diseases including psoriasis
    Patent number: 7863429
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: January 4, 2011
    Assignees: QLT Inc., Sunnybrook and Women's College and Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan, David W. C. Hunt, Jing-Song Tao, Ladan Fazli
  • Integrin-linked kinase and its uses
    Publication number: 20070203326
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: February 6, 2007
    Publication date: August 30, 2007
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its uses
    Patent number: 7189802
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: March 13, 2007
    Assignee: Sunnybrook Health Sciences Centre
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Beta-parvin expression for use in diagnostic methods for assessment of breast cancer
    Publication number: 20060211008
    Abstract: The invention is directed to polynucleotides encoding ?-parvin, a newly identified tumor suppressor gene the alteration of which is involved in the occurrence of breast cancer in a patient, as well as to corresponding expressed polypeptides. The invention also concerns diagnostic methods using the ?-parvin polynucleotides and/or peptides and embodiments thereof as diagnostic or therapeutic tools for breast cancer or in assays to identify pharmacological agents for the treatment of breast cancer.
    Type: Application
    Filed: September 22, 2005
    Publication date: September 21, 2006
    Inventors: Perry Mongroo, Greg Hannigan
  • Integrin-linked kinase and its uses
    Publication number: 20040106107
    Abstract: Methods for isolating ILK genes are provided.. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: September 28, 2001
    Publication date: June 3, 2004
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its uses
    Patent number: 6699983
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: March 2, 2004
    Assignee: Sunnybrook Health Sciences Centre
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Treatment of inflammatory diseases including psoriasis
    Publication number: 20020155179
    Abstract: Inhibitors of integrin-linked kinase (ILK) are used in the treatment of inflammatory disease, including cutaneous inflammatory diseases, such as psoriasis, scleroderma, systemic lupus erythematosus and atopic dermatitis.
    Type: Application
    Filed: November 30, 2001
    Publication date: October 24, 2002
    Inventors: Shoukat Dedhar, Greg Hannigan, David W.C. Hunt, Jing-Song Tao, Ladan Fazli
  • Integrin-linked kinase and its uses
    Publication number: 20020122801
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Application
    Filed: April 23, 2001
    Publication date: September 5, 2002
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its use
    Publication number: 20020107216
    Abstract: ILK genetic sequences and methods of use are provided. Antisense oligonucleotides complementary to ILK are useful in downregulating expression for therapeutic and investigative purposes.
    Type: Application
    Filed: August 8, 2001
    Publication date: August 8, 2002
    Inventors: Shoukat Dedhar, Greg Hannigan, Arthur Yee
  • Integrin-linked kinase and its uses
    Patent number: 6369205
    Abstract: Methods for isolating ILK genes are provided, The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: May 9, 2000
    Date of Patent: April 9, 2002
    Assignee: Sunnybrook Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its uses
    Patent number: 6338958
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: January 15, 2002
    Assignee: Sunnybrook Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its uses
    Patent number: 6013782
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: October 21, 1997
    Date of Patent: January 11, 2000
    Assignee: Sunnybrook Health Sciences Center
    Inventors: Shoukat Dedhar, Greg Hannigan
  • Integrin-linked kinase and its use
    Patent number: 6001622
    Abstract: Methods for isolating ILK genes are provided. The ILK nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as identification of cell type based on expression, and the like.
    Type: Grant
    Filed: March 5, 1998
    Date of Patent: December 14, 1999
    Assignee: Sunnybrook Health Science Centre
    Inventors: Shoukat Dedhar, Greg Hannigan